Global Gene Modifying Immunotherapy for Blood Cancer Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gene Modifying Immunotherapy for Blood Cancer market size will reach US$ million by 2031.
Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two types: one in which the patient receives genetically modified immune cells from a donor, and the other in which the patient's own immune cells are removed, genetically modified and then given back to the patient.CAR T cell therapy involves genetically altering immune system T cells to produce a protein called CAR or chimeric antigen receptor protein, which helps T cells attach to specific proteins on the surface of tumor cells, making it easier for them to recognize cancer cells.
United States market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Modifying Immunotherapy for Blood Cancer players cover Novartis, Kite Pharma, Juno Therapeutics, Cellectis, Ziopharm Oncology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gene Modifying Immunotherapy for Blood Cancer Industry Forecast” looks at past sales and reviews total world Gene Modifying Immunotherapy for Blood Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Modifying Immunotherapy for Blood Cancer sales for 2025 through 2031. With Gene Modifying Immunotherapy for Blood Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Modifying Immunotherapy for Blood Cancer industry.
This Insight Report provides a comprehensive analysis of the global Gene Modifying Immunotherapy for Blood Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Modifying Immunotherapy for Blood Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Modifying Immunotherapy for Blood Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Modifying Immunotherapy for Blood Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Modifying Immunotherapy for Blood Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Modifying Immunotherapy for Blood Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two types: one in which the patient receives genetically modified immune cells from a donor, and the other in which the patient's own immune cells are removed, genetically modified and then given back to the patient.CAR T cell therapy involves genetically altering immune system T cells to produce a protein called CAR or chimeric antigen receptor protein, which helps T cells attach to specific proteins on the surface of tumor cells, making it easier for them to recognize cancer cells.
United States market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Modifying Immunotherapy for Blood Cancer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Modifying Immunotherapy for Blood Cancer players cover Novartis, Kite Pharma, Juno Therapeutics, Cellectis, Ziopharm Oncology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Gene Modifying Immunotherapy for Blood Cancer Industry Forecast” looks at past sales and reviews total world Gene Modifying Immunotherapy for Blood Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Modifying Immunotherapy for Blood Cancer sales for 2025 through 2031. With Gene Modifying Immunotherapy for Blood Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Modifying Immunotherapy for Blood Cancer industry.
This Insight Report provides a comprehensive analysis of the global Gene Modifying Immunotherapy for Blood Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Modifying Immunotherapy for Blood Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Modifying Immunotherapy for Blood Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Modifying Immunotherapy for Blood Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Modifying Immunotherapy for Blood Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Modifying Immunotherapy for Blood Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CAR T-cell Therapy
- TCR T-cell Therapy
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- B Cell Lymphoma
- Multiple Myeloma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Kite Pharma
- Juno Therapeutics
- Cellectis
- Ziopharm Oncology
- Celyad
- Bluebird Bio
- Bellicum Pharmaceuticals
- Mustang Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size (2020-2031)
2.1.2 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Modifying Immunotherapy for Blood Cancer by Country/Region (2020, 2024 & 2031)
2.2 Gene Modifying Immunotherapy for Blood Cancer Segment by Type
2.2.1 CAR T-cell Therapy
2.2.2 TCR T-cell Therapy
2.3 Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
2.3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
2.4 Gene Modifying Immunotherapy for Blood Cancer Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 Chronic Lymphocytic Leukemia
2.4.3 B Cell Lymphoma
2.4.4 Multiple Myeloma
2.4.5 Other
2.5 Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
2.5.1 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
3 GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER MARKET SIZE BY PLAYER
3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Player
3.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Player (2020-2025)
3.1.2 Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player (2020-2025)
3.2 Global Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER BY REGION
4.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025)
4.2 Global Gene Modifying Immunotherapy for Blood Cancer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.4 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.5 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025)
5.2 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
5.3 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025)
6.2 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
6.3 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025)
7.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
7.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer by Region (2020-2025)
8.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER MARKET FORECAST
10.1 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.1.2 Americas Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.3 APAC Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.4 Europe Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.5 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2 Americas Gene Modifying Immunotherapy for Blood Cancer Forecast by Country (2026-2031)
10.2.1 United States Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.2 Canada Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.3 Mexico Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.4 Brazil Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3 APAC Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.3.1 China Gene Modifying Immunotherapy for Blood Cancer Market Forecast
10.3.2 Japan Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.3 Korea Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.4 Southeast Asia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.5 India Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.6 Australia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4 Europe Gene Modifying Immunotherapy for Blood Cancer Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.2 France Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.3 UK Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.4 Italy Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.5 Russia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.2 South Africa Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.3 Israel Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.4 Turkey Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.6 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Type (2026-2031)
10.7 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Modifying Immunotherapy for Blood Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.1.3 Novartis Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.2.3 Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Juno Therapeutics
11.3.1 Juno Therapeutics Company Information
11.3.2 Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.3.3 Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Juno Therapeutics Main Business Overview
11.3.5 Juno Therapeutics Latest Developments
11.4 Cellectis
11.4.1 Cellectis Company Information
11.4.2 Cellectis Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.4.3 Cellectis Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cellectis Main Business Overview
11.4.5 Cellectis Latest Developments
11.5 Ziopharm Oncology
11.5.1 Ziopharm Oncology Company Information
11.5.2 Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.5.3 Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Ziopharm Oncology Main Business Overview
11.5.5 Ziopharm Oncology Latest Developments
11.6 Celyad
11.6.1 Celyad Company Information
11.6.2 Celyad Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.6.3 Celyad Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Celyad Main Business Overview
11.6.5 Celyad Latest Developments
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Information
11.7.2 Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.7.3 Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bluebird Bio Main Business Overview
11.7.5 Bluebird Bio Latest Developments
11.8 Bellicum Pharmaceuticals
11.8.1 Bellicum Pharmaceuticals Company Information
11.8.2 Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.8.3 Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bellicum Pharmaceuticals Main Business Overview
11.8.5 Bellicum Pharmaceuticals Latest Developments
11.9 Mustang Bio
11.9.1 Mustang Bio Company Information
11.9.2 Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.9.3 Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Mustang Bio Main Business Overview
11.9.5 Mustang Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size (2020-2031)
2.1.2 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Modifying Immunotherapy for Blood Cancer by Country/Region (2020, 2024 & 2031)
2.2 Gene Modifying Immunotherapy for Blood Cancer Segment by Type
2.2.1 CAR T-cell Therapy
2.2.2 TCR T-cell Therapy
2.3 Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
2.3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
2.4 Gene Modifying Immunotherapy for Blood Cancer Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 Chronic Lymphocytic Leukemia
2.4.3 B Cell Lymphoma
2.4.4 Multiple Myeloma
2.4.5 Other
2.5 Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
2.5.1 Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
3 GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER MARKET SIZE BY PLAYER
3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Player
3.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Player (2020-2025)
3.1.2 Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player (2020-2025)
3.2 Global Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER BY REGION
4.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025)
4.2 Global Gene Modifying Immunotherapy for Blood Cancer Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.4 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.5 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025)
5.2 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
5.3 Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025)
6.2 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
6.3 APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025)
7.2 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
7.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer by Region (2020-2025)
8.2 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE MODIFYING IMMUNOTHERAPY FOR BLOOD CANCER MARKET FORECAST
10.1 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.1.2 Americas Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.3 APAC Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.4 Europe Gene Modifying Immunotherapy for Blood Cancer Forecast
10.1.5 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2 Americas Gene Modifying Immunotherapy for Blood Cancer Forecast by Country (2026-2031)
10.2.1 United States Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.2 Canada Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.3 Mexico Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.2.4 Brazil Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3 APAC Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.3.1 China Gene Modifying Immunotherapy for Blood Cancer Market Forecast
10.3.2 Japan Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.3 Korea Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.4 Southeast Asia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.5 India Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.3.6 Australia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4 Europe Gene Modifying Immunotherapy for Blood Cancer Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.2 France Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.3 UK Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.4 Italy Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.4.5 Russia Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5 Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.2 South Africa Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.3 Israel Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.5.4 Turkey Market Gene Modifying Immunotherapy for Blood Cancer Forecast
10.6 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Type (2026-2031)
10.7 Global Gene Modifying Immunotherapy for Blood Cancer Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Modifying Immunotherapy for Blood Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.1.3 Novartis Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.2.3 Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Juno Therapeutics
11.3.1 Juno Therapeutics Company Information
11.3.2 Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.3.3 Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Juno Therapeutics Main Business Overview
11.3.5 Juno Therapeutics Latest Developments
11.4 Cellectis
11.4.1 Cellectis Company Information
11.4.2 Cellectis Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.4.3 Cellectis Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cellectis Main Business Overview
11.4.5 Cellectis Latest Developments
11.5 Ziopharm Oncology
11.5.1 Ziopharm Oncology Company Information
11.5.2 Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.5.3 Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Ziopharm Oncology Main Business Overview
11.5.5 Ziopharm Oncology Latest Developments
11.6 Celyad
11.6.1 Celyad Company Information
11.6.2 Celyad Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.6.3 Celyad Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Celyad Main Business Overview
11.6.5 Celyad Latest Developments
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Information
11.7.2 Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.7.3 Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bluebird Bio Main Business Overview
11.7.5 Bluebird Bio Latest Developments
11.8 Bellicum Pharmaceuticals
11.8.1 Bellicum Pharmaceuticals Company Information
11.8.2 Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.8.3 Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Bellicum Pharmaceuticals Main Business Overview
11.8.5 Bellicum Pharmaceuticals Latest Developments
11.9 Mustang Bio
11.9.1 Mustang Bio Company Information
11.9.2 Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
11.9.3 Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Mustang Bio Main Business Overview
11.9.5 Mustang Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Modifying Immunotherapy for Blood Cancer Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CAR T-cell Therapy
Table 4. Major Players of TCR T-cell Therapy
Table 5. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Table 8. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player (2020-2025)
Table 13. Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Products Offered
Table 14. Gene Modifying Immunotherapy for Blood Cancer Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Modifying Immunotherapy for Blood Cancer
Table 39. Key Market Challenges & Risks of Gene Modifying Immunotherapy for Blood Cancer
Table 40. Key Industry Trends of Gene Modifying Immunotherapy for Blood Cancer
Table 41. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 46. Novartis Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 47. Novartis Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Kite Pharma Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 51. Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 52. Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Kite Pharma Main Business
Table 54. Kite Pharma Latest Developments
Table 55. Juno Therapeutics Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 56. Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 57. Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Juno Therapeutics Main Business
Table 59. Juno Therapeutics Latest Developments
Table 60. Cellectis Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 61. Cellectis Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 62. Cellectis Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Cellectis Main Business
Table 64. Cellectis Latest Developments
Table 65. Ziopharm Oncology Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 66. Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 67. Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Ziopharm Oncology Main Business
Table 69. Ziopharm Oncology Latest Developments
Table 70. Celyad Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 71. Celyad Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 72. Celyad Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Celyad Main Business
Table 74. Celyad Latest Developments
Table 75. Bluebird Bio Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 76. Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 77. Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bluebird Bio Main Business
Table 79. Bluebird Bio Latest Developments
Table 80. Bellicum Pharmaceuticals Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 81. Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 82. Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bellicum Pharmaceuticals Main Business
Table 84. Bellicum Pharmaceuticals Latest Developments
Table 85. Mustang Bio Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 86. Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 87. Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Mustang Bio Main Business
Table 89. Mustang Bio Latest Developments
Table 1. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Modifying Immunotherapy for Blood Cancer Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CAR T-cell Therapy
Table 4. Major Players of TCR T-cell Therapy
Table 5. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Table 8. Gene Modifying Immunotherapy for Blood Cancer Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player (2020-2025)
Table 13. Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Products Offered
Table 14. Gene Modifying Immunotherapy for Blood Cancer Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Modifying Immunotherapy for Blood Cancer Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Modifying Immunotherapy for Blood Cancer
Table 39. Key Market Challenges & Risks of Gene Modifying Immunotherapy for Blood Cancer
Table 40. Key Industry Trends of Gene Modifying Immunotherapy for Blood Cancer
Table 41. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 46. Novartis Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 47. Novartis Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Kite Pharma Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 51. Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 52. Kite Pharma Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Kite Pharma Main Business
Table 54. Kite Pharma Latest Developments
Table 55. Juno Therapeutics Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 56. Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 57. Juno Therapeutics Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Juno Therapeutics Main Business
Table 59. Juno Therapeutics Latest Developments
Table 60. Cellectis Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 61. Cellectis Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 62. Cellectis Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Cellectis Main Business
Table 64. Cellectis Latest Developments
Table 65. Ziopharm Oncology Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 66. Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 67. Ziopharm Oncology Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Ziopharm Oncology Main Business
Table 69. Ziopharm Oncology Latest Developments
Table 70. Celyad Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 71. Celyad Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 72. Celyad Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Celyad Main Business
Table 74. Celyad Latest Developments
Table 75. Bluebird Bio Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 76. Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 77. Bluebird Bio Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bluebird Bio Main Business
Table 79. Bluebird Bio Latest Developments
Table 80. Bellicum Pharmaceuticals Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 81. Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 82. Bellicum Pharmaceuticals Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Bellicum Pharmaceuticals Main Business
Table 84. Bellicum Pharmaceuticals Latest Developments
Table 85. Mustang Bio Details, Company Type, Gene Modifying Immunotherapy for Blood Cancer Area Served and Its Competitors
Table 86. Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Product Offered
Table 87. Mustang Bio Gene Modifying Immunotherapy for Blood Cancer Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Mustang Bio Main Business
Table 89. Mustang Bio Latest Developments
LIST OF FIGURES
Figure 1. Gene Modifying Immunotherapy for Blood Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Modifying Immunotherapy for Blood Cancer Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Modifying Immunotherapy for Blood Cancer Sales Market Share by Country/Region (2024)
Figure 8. Gene Modifying Immunotherapy for Blood Cancer Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type in 2024
Figure 10. Gene Modifying Immunotherapy for Blood Cancer in Acute Lymphocytic Leukemia
Figure 11. Global Gene Modifying Immunotherapy for Blood Cancer Market: Acute Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. Gene Modifying Immunotherapy for Blood Cancer in Chronic Lymphocytic Leukemia
Figure 13. Global Gene Modifying Immunotherapy for Blood Cancer Market: Chronic Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 14. Gene Modifying Immunotherapy for Blood Cancer in B Cell Lymphoma
Figure 15. Global Gene Modifying Immunotherapy for Blood Cancer Market: B Cell Lymphoma (2020-2025) & ($ millions)
Figure 16. Gene Modifying Immunotherapy for Blood Cancer in Multiple Myeloma
Figure 17. Global Gene Modifying Immunotherapy for Blood Cancer Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 18. Gene Modifying Immunotherapy for Blood Cancer in Other
Figure 19. Global Gene Modifying Immunotherapy for Blood Cancer Market: Other (2020-2025) & ($ millions)
Figure 20. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application in 2024
Figure 21. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player in 2024
Figure 22. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Figure 23. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 24. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 25. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 27. Americas Gene Modifying Immunotherapy for Blood Cancer Value Market Share by Country in 2024
Figure 28. United States Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region in 2024
Figure 33. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 34. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 35. China Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 39. India Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country in 2024
Figure 42. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 43. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 44. Germany Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 45. France Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 58. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 59. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 61. United States Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 62. Canada Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 63. Mexico Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 64. Brazil Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 65. China Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 66. Japan Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 67. Korea Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 69. India Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 70. Australia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 71. Germany Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 72. France Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 73. UK Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 74. Italy Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 75. Russia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 76. Egypt Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 77. South Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 78. Israel Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 79. Turkey Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 80. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 1. Gene Modifying Immunotherapy for Blood Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Modifying Immunotherapy for Blood Cancer Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Modifying Immunotherapy for Blood Cancer Sales Market Share by Country/Region (2024)
Figure 8. Gene Modifying Immunotherapy for Blood Cancer Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type in 2024
Figure 10. Gene Modifying Immunotherapy for Blood Cancer in Acute Lymphocytic Leukemia
Figure 11. Global Gene Modifying Immunotherapy for Blood Cancer Market: Acute Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. Gene Modifying Immunotherapy for Blood Cancer in Chronic Lymphocytic Leukemia
Figure 13. Global Gene Modifying Immunotherapy for Blood Cancer Market: Chronic Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 14. Gene Modifying Immunotherapy for Blood Cancer in B Cell Lymphoma
Figure 15. Global Gene Modifying Immunotherapy for Blood Cancer Market: B Cell Lymphoma (2020-2025) & ($ millions)
Figure 16. Gene Modifying Immunotherapy for Blood Cancer in Multiple Myeloma
Figure 17. Global Gene Modifying Immunotherapy for Blood Cancer Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 18. Gene Modifying Immunotherapy for Blood Cancer in Other
Figure 19. Global Gene Modifying Immunotherapy for Blood Cancer Market: Other (2020-2025) & ($ millions)
Figure 20. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application in 2024
Figure 21. Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Player in 2024
Figure 22. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Figure 23. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 24. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 25. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2020-2025 ($ millions)
Figure 27. Americas Gene Modifying Immunotherapy for Blood Cancer Value Market Share by Country in 2024
Figure 28. United States Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region in 2024
Figure 33. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 34. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 35. China Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 39. India Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Country in 2024
Figure 42. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 43. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 44. Germany Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 45. France Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Gene Modifying Immunotherapy for Blood Cancer Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 58. APAC Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 59. Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 61. United States Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 62. Canada Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 63. Mexico Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 64. Brazil Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 65. China Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 66. Japan Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 67. Korea Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 69. India Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 70. Australia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 71. Germany Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 72. France Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 73. UK Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 74. Italy Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 75. Russia Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 76. Egypt Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 77. South Africa Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 78. Israel Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 79. Turkey Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
Figure 80. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Gene Modifying Immunotherapy for Blood Cancer Market Size 2026-2031 ($ millions)
More Publications
Global Pyrotinib Market Growth 2025-2031
US$ 3,660.00
December 2025
75 pages
Global Retinol (Vitamin A) Market Growth 2024-2030
US$ 3,660.00
March 2024
94 pages
